v3.26.1
SEGMENT REPORTING (Tables)
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment

 

 

 

Three-Months Ended
March 31

 

 

 

 

2026

 

 

2025

 

 

Expenses:

 

 

 

 

 

 

 

Research and development:

 

 

 

 

 

 

 

SP-3164

$

 

15,160

 

$

 

21,037

 

 

SP-2577

 

 

8,310

 

 

 

54,495

 

 

IMP3ACT (Designable Multi-Antivirals)

 

 

726,343

 

 

 

-

 

 

General and administrative:

 

 

 

 

 

 

 

Professional services and Consulting

 

 

902,563

 

 

 

1,233,695

 

 

Personnel cost

 

 

435,058

 

 

 

251,108

 

 

Insurance expenses

 

 

119,083

 

 

 

128,953

 

 

Facility cost and other

 

 

77,222

 

 

 

29,407

 

 

Loss from operations

 

 

2,283,739

 

 

 

1,718,695

 

 

Interest income, net

 

 

59,111

 

 

 

9,162

 

 

Net loss

$

 

2,224,628

 

$

 

1,709,533